Pharma GCC Setup in India for Global Pharma Companies
We help global pharma majors and emerging biotech build US FDA, EMA, MHRA and PMDA-compliant Global Capability Centres in India across GLP-1, oncology, biosimilars, vaccines, cell & gene therapy, CNS, generics and AI-led discovery, spanning Hyderabad, Pune, Mumbai and Bangalore.
Practice leadership averages 25+ years across Torrent, Cipla, Lupin, Sun and Dr Reddy's.
16 GCC calculators with Pharma / Life Sciences benchmarks across 50+ currencies and 10k FTEs.
21 CFR Part 11, EU Annex 11, ICH-GCP/GLP/GMP, GAMP 5, DPDP, GDPR, HIPAA, Schedule M.
India Pharma GCC by the numbers
Fastest growing life-sciences captive market globally, 18% CAGR.
Clinical, biostats, regulatory, pharmacovigilance, medical writing, RWE.
Largest pharma manufacturing and R&D cluster in the country.
India supplies 20% of global generic medicines and 60% of vaccines.
55 to 70% cheaper than US / EU for equivalent regulated talent.
More than any country outside the US. EMA, MHRA, PMDA fluent.
Therapeutic & modality bouquet we build for
GLP-1 is just one of many. We run GCC build-out across the full pharma portfolio, mapped to the right city, talent pool and regulatory pathway.
GLP-1 example: India semaglutide patent expiry March 2026 unlocked 8+ generic brands and a ~Rs 5,000 Cr domestic plus 100+ export market opportunity. We run the global SEO/AEO, PV, RWE and HCP-engagement spine from India.
GLP-1 & Cardio-Metabolic
Semaglutide, tirzepatide, retatrutide programmes. India patent expiry March 2026 unlocked 8+ generic brands. GCCs run global CMC, PV, RWE, market-access and HCP-engagement for GLP-1, SGLT2, GIP/GLP and obesity pipelines across 100+ markets.
Oncology & Targeted Therapy
ADCs, bispecifics, CAR-T, PROTACs, KRAS/EGFR inhibitors. End-to-end clinical operations, biomarker analytics, companion diagnostics, biostats and submissions for solid-tumour and haem-onc portfolios.
Biosimilars & Biologics
mAbs, fusion proteins, insulins, GLP analogues. Process R&D, analytical characterisation, comparability, BLA / 351(k) / EMA biosimilar dossiers, global PV and lifecycle management.
Cell & Gene Therapy (CGT)
AAV, lentiviral, ex-vivo CAR-T and in-vivo gene editing. Bioprocess R&D, vector analytics, GMP MS&T support, clinical operations and regulatory strategy for FDA / EMA / PMDA / CDSCO.
Vaccines & Infectious Disease
mRNA, viral vector, recombinant subunit, conjugate vaccines. Bharat Biotech, Serum, Bio E ecosystem. GCCs run global PV, regulatory, clinical and bioprocess analytics out of Hyderabad and Pune.
CNS, Rare & Orphan Diseases
Neurology, psychiatry, Alzheimer’s, Parkinson’s, MS, rare metabolic and neuromuscular indications. Patient-registry analytics, RWE, medical writing and orphan-drug regulatory strategy.
Cardio-Renal-Metabolic
HFpEF, CKD, NASH/MASH, T2DM, dyslipidaemia. India runs global biostats CoEs, late-phase trials, HEOR and market-access modelling for cardio-renal pipelines across emerging and developed markets.
Generics, Specialty & Complex Generics
505(b)(2), complex injectables, inhalation, ophthalmics, transdermals. ANDA / DMF authoring, bioequivalence biostats, post-approval lifecycle and global PV for generics majors.
Consumer Health & OTC
OTC switch strategy, consumer insights, digital commerce analytics, omnichannel marketing, demand sensing and e-pharmacy integrations for global OTC and self-care portfolios.
AI-Led Drug Discovery & Genomics
Target ID, ML for lead optimisation, structural biology, NGS bioinformatics, federated RWE, synthetic biology and computational chemistry. Pair with hyperscaler cloud and HPC.
Pharma GCC capabilities we build
From early discovery to commercial operations, end-to-end pharma value chain delivered from India.
Clinical Operations
CRA oversight, monitoring, site management, EDC build, study start-up, central lab coordination across Phase I-IV.
Biostatistics & SAS Programming
Statistical analysis, SAP authoring, SDTM/ADaM datasets, TLF production, integrated summaries for NDA/BLA/MAA.
Pharmacovigilance
ICSR case processing in Argus, PSUR/PBRER authoring, signal detection, literature monitoring, aggregate safety reports.
Regulatory Affairs
CTD / eCTD authoring, labelling, lifecycle maintenance, agency response handling for FDA, EMA, MHRA, PMDA, CDSCO.
Medical Writing
Protocols, CSRs, IBs, manuscripts, plain-language summaries, RWE publications and regulatory narratives.
Medical Affairs & HEOR
Medical information, MSL support, scientific communication, real-world evidence, HEOR modelling and budget impact.
Commercial Ops & Analytics
Sales operations, omnichannel marketing analytics, CRM (Veeva), incentive comp, market-access and pricing analytics.
R&D Chemistry & Formulation
API process R&D, formulation development, analytical method development, stability and CMC documentation.
Biotech, Genomics & AI Discovery
NGS pipelines, target ID, AI/ML for lead optimisation, structural biology, computational chemistry, vaccine bioprocess.
Which Indian city for your Pharma GCC?
Most global pharma majors run a hub-and-spoke. Dive into each city playbook.
Hyderabad
Genome Valley (Asia’s largest life-sciences cluster), Bharat Biotech, Biological E, Dr Reddy’s, Aurobindo, Divi’s. Novartis, Sanofi, GSK, BMS, Pfizer, Bayer R&D and clinical captives.
- Biostatistics & SAS Clinical
- Vaccine R&D & genomics
- Regulatory CMC & API
- Pharmacovigilance at scale
- Bulk drug & process R&D
Pune
Cipla, Lupin, Serum Institute, Emcure, NCL Pune PhD pipeline, IISER and IIT-B proximity. Strongest formulation, chemistry, CDM and PV pool at 20% lower cost than Bangalore.
- Clinical Data Management
- Pharmacovigilance (Argus)
- Medical Writing
- Formulation & analytical R&D
- Veeva Vault & Medidata teams
Mumbai
Indian HQs of nearly every global pharma (Pfizer, J&J, Novartis, Sanofi, Roche, GSK, Abbott). CDSCO and DCGI proximity. Deepest commercial ops, market-access and HEOR pool.
- Regulatory affairs & submissions
- Commercial ops & market access
- HEOR & RWE analytics
- Finance & GBS for pharma
- Medical affairs leadership
Bangalore
Biocon, Strand, Mapmygenome, IISc, NCBS. Strongest biotech, bioinformatics, AI-for-discovery, digital health and RWE analytics pool. Pair with hyperscaler cloud for data platforms.
- Bioinformatics & genomics
- AI for drug discovery
- Digital health & wearables
- RWE / HEOR data engineering
- Veeva / SAS / Snowflake platforms
Hyderabad vs Pune vs Mumbai vs Bangalore for Pharma GCCs
A side-by-side comparison across pharma capabilities, operating economics and regulator proximity. Built to help global pharma decision-makers shortlist the right Indian city for their GCC build-out.
Capability fit by city
Where each city wins across the pharma & life-sciences GCC value chain.
| Capability | Hyderabad | Pune | Mumbai | Bangalore |
|---|---|---|---|---|
| Vaccine R&D & bioprocess | Best | Strong | Good | Good |
| Bulk drug / API / CMC | Best | Good | Good | Limited |
| Biostatistics & SAS clinical | Best | Strong | Good | Strong |
| Pharmacovigilance (Argus) | Strong | Best | Strong | Good |
| Clinical Data Management | Good | Best | Good | Strong |
| Medical writing & scientific comms | Good | Best | Strong | Good |
| Formulation & analytical R&D | Strong | Best | Good | Limited |
| Regulatory affairs & submissions | Strong | Strong | Best | Good |
| Medical affairs leadership | Good | Good | Best | Good |
| HEOR & RWE analytics | Good | Good | Best | Best |
| Commercial ops & market access | Good | Good | Best | Strong |
| AI for drug discovery | Good | Good | Good | Best |
| Bioinformatics & genomics | Strong | Good | Good | Best |
| Digital health & wearables | Good | Good | Strong | Best |
| Veeva / Salesforce platform engg | Strong | Strong | Strong | Best |
| F&A / GBS for pharma | Strong | Best | Best | Strong |
Ecosystem & operating economics
Numbers that move the business case. Indicative ranges; use the ROI calculator for your specific scenario.
| Dimension | Hyderabad | Pune | Mumbai | Bangalore |
|---|---|---|---|---|
| Indicative fully-loaded cost / FTE | USD 30 to 50K | USD 28 to 48K | USD 38 to 65K | USD 35 to 60K |
| Grade-A office rent / sqft / month | Rs 70-110 | Rs 80-130 | Rs 180 to 450 (BKC) | Rs 110-170 |
| Pharma talent pool size | ~120k | ~95k | ~80k | ~140k (tech-led) |
| Annual life-sciences graduates | ~25,000 | ~30,000 | ~12,000 | ~20,000 |
| Attrition for regulated PV / CDM | 14 to 18% | 12 to 16% | 15 to 20% | 18 to 24% |
| Regulator proximity (CDSCO / DCGI) | Zonal CDSCO | Zonal CDSCO | CDSCO HQ / FDA-MH | Zonal CDSCO |
| Number of US-FDA approved sites nearby | 180+ | 90+ | 70+ | 50+ |
Pharma GCC cost estimator
Indicative fully-loaded India cost vs US / EU baseline. For detailed scenarios use the full ROI calculators.
Indicative estimates. Real numbers depend on grade mix, role, location, attrition assumptions and infra. Validated by 25+ year pharma operators ex-Torrent, Cipla.
Pharma industry experts with 25+ years of leadership
Our Pharma & Life Sciences GCC practice is led by operators, not consultants. People who have built R&D centres, run global PV hubs, signed off FDA inspections and launched biosimilars at scale.
Ex-Torrent, Cipla, Lupin, Sun, Dr Reddy’s leadership
Operators who have run R&D, regulatory, manufacturing and commercial functions at India’s top pharma majors.
Ex-Pfizer, J&J
Global majors’ GCC build-out, PV hubs, clinical CoEs and commercial analytics at scale.
25+ years average leadership tenure
CXOs and Directors who have personally signed off FDA / EMA / PMDA inspections and led ANDA, NDA, BLA and biosimilar filings.
Validated playbooks
Reusable blueprints for PV migrations, clinical CoE setup, biosimilars BLA, vaccine PV and AI-discovery cells.
Regulatory & compliance fluency
Inspection-ready captives. Validated environments. Audit trail by design. Every Pharma GCC we build is set up to clear FDA, EMA, MHRA, PMDA, CDSCO and ANVISA inspections from Day 1.
Tech & platform expertise
Engineers, statisticians and clinicians trained on the platforms your global teams already use.
Pharma GCC archetypes we deliver
Global R&D Centre
Owns end-to-end programmes: discovery, clinical, biostats, regulatory, medical writing.
Pharmacovigilance Hub
Single global PV operating centre for ICSR processing, aggregate reports and signal detection.
Clinical Data & Biostats CoE
CDM, SAS programming, biostatistics and statistical reporting for global trials.
Regulatory & Medical Writing CoE
Submissions, lifecycle, labelling and scientific writing across markets.
Commercial Analytics & RWE Hub
HEOR, RWE, market-access, sales ops and omnichannel analytics.
Innovation & AI-Discovery Cell
AI/ML for target discovery, genomics, digital health and wearables.
Model your Pharma GCC business case
12 purpose-built ROI calculators with Pharma / Life Sciences benchmarks across PV, biostats, regulatory, clinical and commercial roles. 50+ currencies. Scales up to 10,000 FTE captives. Export the result as a branded PDF.
Talent pipeline that scales with you
120,000+ life-sciences GCC professionals across India. PhD bench at IISc, IISER, IIT Bombay, NCL Pune, NIPER and ICMR. Annual output of 100,000+ life-sciences graduates plus a deep pool of PharmD, MBBS-MD and bioinformatics specialists. Attrition for regulated PV / RA / biostats roles is the lowest in the GCC ecosystem.
Talk to us about your GCC
Get a tailored India GCC blueprint within one business day. Or call, WhatsApp us right now.